🎉 M&A multiples are live!
Check it out!

ESSA Pharma Valuation Multiples

Discover revenue and EBITDA valuation multiples for ESSA Pharma and similar public comparables like Pharming, Galapagos, and Benevolent AI.

ESSA Pharma Overview

About ESSA Pharma

ESSA Pharma Inc is a pharmaceutical company. The company was focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It was developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. Currently, the company has terminated its clinical trials and other studies.


Founded

2009

HQ

United States of America
Employees

35

Website

essapharma.com

Financials

LTM Revenue n/a

LTM EBITDA n/a

EV

-$46.9M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

ESSA Pharma Financials

ESSA Pharma has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.

In the most recent fiscal year, ESSA Pharma achieved revenue of n/a and an EBITDA of -$28.5M.

ESSA Pharma expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See ESSA Pharma valuation multiples based on analyst estimates

ESSA Pharma P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue n/a n/a XXX XXX XXX
Gross Profit n/a n/a XXX XXX XXX
Gross Margin NaN% NaN% XXX XXX XXX
EBITDA -$26.5M -$28.5M XXX XXX XXX
EBITDA Margin -Infinity% -Infinity% XXX XXX XXX
Net Profit -$35.1M -$26.6M XXX XXX XXX
Net Margin -Infinity% -Infinity% XXX XXX XXX
Net Debt n/a n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

ESSA Pharma Stock Performance

As of April 15, 2025, ESSA Pharma's stock price is $2.

ESSA Pharma has current market cap of $73.2M, and EV of -$46.9M.

See ESSA Pharma trading valuation data

ESSA Pharma Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
-$46.9M $73.2M XXX XXX XXX XXX $-0.68

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

ESSA Pharma Valuation Multiples

As of April 15, 2025, ESSA Pharma has market cap of $73.2M and EV of -$46.9M.

ESSA Pharma's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.

Analysts estimate ESSA Pharma's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for ESSA Pharma and 10K+ public comps

ESSA Pharma Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV -$46.9M XXX XXX XXX
EV/Revenue n/a XXX XXX XXX
EV/EBITDA n/a XXX XXX XXX
P/E -2.5x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF n/a XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get ESSA Pharma Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

ESSA Pharma Valuation Multiples

ESSA Pharma's NTM/LTM revenue growth is n/a

ESSA Pharma's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged $1.0M for the same period.

Over next 12 months, ESSA Pharma's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate ESSA Pharma's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for ESSA Pharma and other 10K+ public comps

ESSA Pharma Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth n/a XXX XXX XXX XXX
EBITDA Margin n/a XXX XXX XXX XXX
EBITDA Growth 8% XXX XXX XXX XXX
Rule of 40 (SaaS-only) n/a XXX XXX XXX XXX
Revenue per Employee n/a XXX XXX XXX XXX
Opex per Employee $1.0M XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue n/a XXX XXX XXX XXX
R&D Expenses to Revenue n/a XXX XXX XXX XXX
Opex to Revenue n/a XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

ESSA Pharma Public Comps

See public comps and valuation multiples for Drug Development & Therapeutics and Small Molecules comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Benevolent AI XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

ESSA Pharma M&A and Investment Activity

ESSA Pharma acquired  XXX companies to date.

Last acquisition by ESSA Pharma was  XXXXXXXX, XXXXX XXXXX XXXXXX . ESSA Pharma acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by ESSA Pharma

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About ESSA Pharma

When was ESSA Pharma founded? ESSA Pharma was founded in 2009.
Where is ESSA Pharma headquartered? ESSA Pharma is headquartered in United States of America.
How many employees does ESSA Pharma have? As of today, ESSA Pharma has 35 employees.
Who is the CEO of ESSA Pharma? ESSA Pharma's CEO is Dr. David Ross Parkinson, M.D..
Is ESSA Pharma publicy listed? Yes, ESSA Pharma is a public company listed on NAS.
What is the stock symbol of ESSA Pharma? ESSA Pharma trades under EPIX ticker.
When did ESSA Pharma go public? ESSA Pharma went public in 2015.
Who are competitors of ESSA Pharma? Similar companies to ESSA Pharma include e.g. Julphar, Benevolent AI, Galapagos, Pharming.
What is the current market cap of ESSA Pharma? ESSA Pharma's current market cap is $73.2M
Is ESSA Pharma profitable? Yes, ESSA Pharma is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.